BB
NVO

Burford Brothers’s Novo Nordisk NVO Stock Holding History

Burford Brothers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Hold
9,794
– – 0.17% 115
2026
Q1 		$360K Sell
9,794
-1,004
-9% -$47.6K 0.15% 121
2025
Q4 		$549K Buy
10,798
+717
+7% +$36.7K 0.23% 98
2025
Q3 		$559K Sell
10,081
-745
-7% -$43.6K 0.24% 97
2025
Q2 		$747K Buy
10,826
+745
+7% +$50.7K 0.34% 67
2025
Q1 		$700K Sell
10,081
-20
-0.2% -$1.65K 0.34% 77
2024
Q4 		$869K Hold
10,101
– – 0.43% 53
2024
Q3 		$1.2M Sell
10,101
-202
-2% -$26.9K 0.63% 35
2024
Q2 		$1.47M Sell
10,303
-29
-0.3% -$3.84K 0.85% 28
2024
Q1 		$1.33M Buy
10,332
+228
+2% +$27.1K 0.87% 29
2023
Q4 		$1.05M Buy
+10,104
New +$999K 0.74% 32

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Burford Brothers's NVO Position: Q2 2026 in Review

Burford Brothers held its Novo Nordisk (NVO) position steady in Q2 2026 at 9,794 shares worth $470K. The position accounts for 0.17% of the portfolio, ranked #115.

Burford Brothers first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.47M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Burford Brothers held 9,794 shares of Novo Nordisk worth $470K as of Q2 2026.
  • Burford Brothers left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.17% of Burford Brothers's portfolio in Q2 2026, its #115 holding.
  • Burford Brothers first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Burford Brothers's Novo Nordisk position peaked at $1.47M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.